These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11302489)

  • 1. Glycosylative inactivation of chalcomycin and tylosin by a clinically isolated Nocardia asteroides strain.
    Morisaki N; Hashimoto Y; Furihata K; Yazawa K; Tamura M; Mikami Y
    J Antibiot (Tokyo); 2001 Feb; 54(2):157-65. PubMed ID: 11302489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin.
    Poulsen SM; Kofoed C; Vester B
    J Mol Biol; 2000 Dec; 304(3):471-81. PubMed ID: 11090288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity studies of tylosin-related macrolides.
    Fish SA; Cundliffe E
    J Antibiot (Tokyo); 1996 Oct; 49(10):1044-8. PubMed ID: 8968399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel tylosin analogues generated by a wblA disruption mutant of Streptomyces ansochromogenes.
    Lu C; Liao G; Zhang J; Tan H
    Microb Cell Fact; 2015 Nov; 14():173. PubMed ID: 26525981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of rifampin by Nocardia brasiliensis.
    Yazawa K; Mikami Y; Maeda A; Akao M; Morisaki N; Iwasaki S
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1313-7. PubMed ID: 8328779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic studies on the interaction between a ribosomal complex active in peptide bond formation and the macrolide antibiotics tylosin and erythromycin.
    Dinos GP; Kalpaxis DL
    Biochemistry; 2000 Sep; 39(38):11621-8. PubMed ID: 10995229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of fusidic acid by pathogenic Nocardia.
    Harada K; Tomita K; Fujii K; Sato N; Uchida H; Yazawa K; Mikami Y
    J Antibiot (Tokyo); 1999 Mar; 52(3):335-9. PubMed ID: 10348053
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro susceptibility of pathogenic Nocardia to beta-lactam antibiotics, especially imipenem, a carbapenem antibiotic].
    Yazawa K; Mikami Y; Otozai K; Uno J; Arai T
    Jpn J Antibiot; 1989 Nov; 42(11):2354-62. PubMed ID: 2695658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RS-22A, B and C: new macrolide antibiotics from Streptomyces violaceusniger. II. Physico-chemical properties and structure elucidation.
    Ubukata M; Morita T; Osada H
    J Antibiot (Tokyo); 1995 Apr; 48(4):293-9. PubMed ID: 7775265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical transformation of tylosin derivatives into neutral macrolides having a 3'-methoxyl group.
    Gotoh Y; Saitoh H; Miyake T
    Carbohydr Res; 1998 Jun; 309(1):45-55. PubMed ID: 9720235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro antimicrobial activity of 3-keto 16-membered macrolides derived from tylosin.
    Creemer LC; Toth JE; Kirst HA
    J Antibiot (Tokyo); 2002 Apr; 55(4):427-36. PubMed ID: 12061552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced production of nargenicin A(1) and generation of novel glycosylated derivatives.
    Dhakal D; Le TT; Pandey RP; Jha AK; Gurung R; Parajuli P; Pokhrel AR; Yoo JC; Sohng JK
    Appl Biochem Biotechnol; 2015 Mar; 175(6):2934-49. PubMed ID: 25577346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peptide derivatives of tylosin-related macrolides].
    Korshunova GA; Sumbatian NV; Fedorova NV; Kuznetsova IV; Shishkina AV; Bogdanov AA
    Bioorg Khim; 2007; 33(2):235-44. PubMed ID: 17476984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrrolosporin A, a new antitumor antibiotic from Micromonospora sp. C39217-R109-7. II. Isolation, physico-chemical properties, spectroscopic study and X-ray analysis.
    Schroeder DR; Colson KL; Klohr SE; Lee MS; Matson JA; Brinen LS; Clardy J
    J Antibiot (Tokyo); 1996 Sep; 49(9):865-72. PubMed ID: 8931719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New amidino-benzimidazolyl derivatives of tylosin and desmycosin.
    Hranjec M; Starcević K; Zamola B; Mutak S; Derek M; Karminski-Zamola G
    J Antibiot (Tokyo); 2002 Mar; 55(3):308-14. PubMed ID: 12014447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural studies of new macrolide antibiotics, shurimycins A and B.
    Kumazawa S; Asami Y; Awane K; Ohtani H; Fukuchi C; Mikawa T; Hayase T
    J Antibiot (Tokyo); 1994 Jun; 47(6):688-96. PubMed ID: 8040074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GERI-155, a new macrolide antibiotic related to chalcomycin.
    Kim SD; Ryoo IJ; Kim CJ; Kim WG; Kim JP; Kong JY; Koshino H; Uramoto M; Yoo ID
    J Antibiot (Tokyo); 1996 Sep; 49(9):955-7. PubMed ID: 8931736
    [No Abstract]   [Full Text] [Related]  

  • 18. Chalcomycin B, a new macrolide antibiotic from the marine isolate Streptomyces sp. B7064.
    Asolkar RN; Maskey RP; Helmke E; Laatsch H
    J Antibiot (Tokyo); 2002 Oct; 55(10):893-8. PubMed ID: 12523822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Studies on Selected Macrolides Active against
    Arsic B; Barber J; Cikos A; Kadirvel M; Kostic E; McBain AJ; Milicevic J; Oates A; Regan A
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthesis of glycosylated derivatives of tylosin in Streptomyces venezuelae.
    Han AR; Park SR; Park JW; Lee EY; Kim DM; Kim BG; Yoon YJ
    J Microbiol Biotechnol; 2011 Jun; 21(6):613-6. PubMed ID: 21715968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.